EndoSonics Corp.

For VolcanoTherapeutics Inc. , the addition of Jomed NV 's IVUS business is both an addition to and diversification beyond its current play in thermography as a diagnostic tool to detect vulnerabl

Rumors about Abbott Laboratories Inc. 's acquisition of struggling European cardiovascular device company Jomed NV [See Deal] were all over this year's Paris Course on Revascularization (PCR) m

One of the few small European players to grow into a major presence in the stent marketplace, Jomed now sets its sights on creating a worldwide, diversified cardiovascular business. by David Cassak Th

Recent research indicates that certain kinds of "vulnerable plaque," may trigger acute coronary events, creating demand for new diagnostic tools and therapeutics. By Wendy Diller Traditional scientifi